Wellington Management

Activity from announced rounds

Activity in this selectionUnited States · Oct 9, 2026 · Jul 12, 2026

Wellington Management is an investment manager with a private-investing platform spanning venture capital, growth and private debt, informed by its public-market research.

Its equity strategies include early-stage venture, private biotech, climate growth and late-stage growth. These teams address different development needs, from scientific breakthroughs and medical demand to scaling industrial systems and preparing for public markets.

A Value Creation Team connects portfolio companies with Wellington’s public- and private-market specialists from seed through IPO. The wider platform also provides growth lending, giving some businesses a debt-financing route alongside equity capital.

Sources
Rounds participated in
4
Confirmed lead rounds
2
1 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$1B
4 disclosed · full round size, not this investor’s share

By stage

Series C+3
Series B1

By primary sector

AI1
Biotech1
Developer tools1
Space tech1

By country

United States4

Rounds

4 in this selection
Temporal

Temporal provides an open-source durable execution platform for long-running applications and AI agents.

$550MSeries E
Lead
Clay

A go-to-market platform that combines customer and prospect data with AI research and automation tools for revenue teams.

$115MSeries D
Lead
Muon Space

Muon Space designs, deploys and operates satellite constellations tailored to customer missions and monitoring needs.

$250MSeries C
Participant
Crystalys Therapeutics

Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout

$130MSeries B
Role not disclosed